Results 151 to 160 of about 254,031 (357)

IMMUNOSUPPRESSIVE AGENTS AND IMMUNE CYTOLYSIS IN VITRO

, 1972
William U. Shipley
openalex   +1 more source

Microphysiological Systems in Cancer Research: Advancing Immunotherapy through Tumor Microenvironment‐Integrated Organ‐On‐Chip Models

Advanced Therapeutics, EarlyView.
Emerging microphysiological systems reproduce the spatial, biochemical, and cellular complexity of the tumor microenvironment, surpassing 2D cultures and murine models. By integrating patient‐derived tumors, perfusable vasculature, and immune trafficking, these organ‐on‐chip platforms reveal mechanisms of immune evasion, predict therapeutic responses ...
Fabiana Moresi, Francesco Noto, Jyothsna Vasudevan, Xavier Bisteau, Giulia Adriani, Andrea Pavesi   +5 more
wiley   +1 more source

Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents. [PDF]

J Enzyme Inhib Med Chem, 2022
Walczak JM, Iwaszkiewicz-Grześ D, Ziomkowska M, Śliwka-Kaszyńska M, Daśko M, Trzonkowski P, Cholewiński G.   +6 more
europepmc   +1 more source

EFFECTS OF IMMUNOSUPPRESSIVE AGENTS ON LEUCOCYTE INTERFERON PRODUCTION IN NORMAL OR THYMUS-DEPRIVED MICE

, 1979
Jean‐Louis Virelizier
openalex   +1 more source

Clinical Course of Patients with Ig A Nephropathy between Combined Treatment of Immunosuppressive Agents and ACE Inhibitor and ACE Inhibitor alone [PDF]

, 2001
You‐Cheol Hwang, Tae Won Lee, Myung Jae Kim, Moon Ho Yang, Chun Gyoo Ihm   +4 more
openalex   +1 more source

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Advanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan, Yaping Chen   +7 more
wiley   +1 more source

Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis [PDF]

, 2001
Tadashi Miyamoto, Akira Matsumori, Myung‐Woo Hwang, Ryosuke Nishio, Haruyasu Ito, Shigetake Sasayama   +5 more
openalex   +1 more source

Genetic Engineering Methods in Primary T Cells

Advanced Therapeutics, EarlyView.
Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley   +1 more source

Immunogenicity and safety of SARS-CoV-2 vaccine with immunosuppressive agents. [PDF]

Pediatr Int, 2022
Kamei K, Ogura M, Sato M, Nishi K, Shoji K, Funaki T, Ogimi C, Ito S.   +7 more
europepmc   +1 more source

Hepatic growth effects of methylprednisolone, azathioprine, mycophenolic acid, and mizoribine [PDF]

, 1993
Azzarone, A, Francavilla, A, Starzl, TE, Zeng, QH   +3 more
core   +1 more source